Norethindrone Acetate And Ethinyl Estradiol Kit
Product Images NDC 0378-7288

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate And Ethinyl Estradiol (NDC 0378-7288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure diagram showing two molecules: Ethinyl Estradiol on top and Norethindrone Acetate below. Each structure includes atomic and bond representations typical of steroid hormone compounds.*

FDA Label Image

Table Ii: Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral Contraceptive Use (Image 02)

A bar chart comparing mortality rates (number of deaths per 100,000 women users) by age groups (15-24, 25-34, 35-44, 45- ) across four categories: ever-users (non-smokers), controls (non-smokers), ever-users (smokers), and controls (smokers). Mortality increases with age, highest in ever-users who are smokers.*

FDA Label Image

Blister Image With Instructions (Image 03)

Illustrative dosing schedule for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL kit showing a weekly pill layout from Sunday to Saturday. It includes directions for both Sunday starters and day-1 starters with instructions to take pills left to right each week. The diagram displays four rows representing weeks 1 to 4 with pill slots and dosage information noted below.*

FDA Label Image

Day Label Sticker (Image 04)

An instructional diagram showing a weekly calendar grid with days listed for each week from Sunday to Saturday and Monday to Sunday in repeating rows. The text instructs to pick the day label strip corresponding to the first day of the menstrual period and place it over the days on the blister pack, starting with Sunday as day 1. It also notes that if the first day of the period is Sunday, this step can be skipped.*

FDA Label Image

Blister Image With Instructions (Image 05)

An instructional diagram showing the weekly pill-taking schedule for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL tablets, 1.5 mg/0.03 mg in a kit form by Mylan Pharmaceuticals Inc. It guides users to start pill taking on Sunday or day 1 of their period, indicating the direction to take pills from left to right across each of the 4 weeks.*

FDA Label Image

Day Label Sticker (Image 06)

An instructional diagram showing how to use a day label strip that aligns with the days of the week, starting with Sunday, to track the start day of a medication kit. The diagram includes rows of days to help place the label strip on the medication blister according to the first day of the user's period.*

FDA Label Image

3s Carton (Image 07)

Packaging label for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL and Ferrous Fumarate Tablets USP 1.5 mg / 0.03 mg kit by Mylan Pharmaceuticals Inc. The label indicates a kit containing 3 pouches, each with one blister pack of 28 tablets. Packaging includes dosage and storage information, manufacturer details, and NDC 0378-7288.*

FDA Label Image

Image 08

A forest plot chart depicting effect estimates from various epidemiological studies comparing combined oral contraceptive (COC) use versus never use. The chart lists study names and years on the left, with horizontal lines representing confidence intervals for odds ratios (OR), relative risks (RR), and hazard ratios (HR) plotted against an effect estimate scale from -1.50 to 2.00 on the x-axis, centered at 1.00.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.